Skip to main content
Book cover

Progranulin pp 145–153Cite as

Methods to Analyze the Role of Progranulin (PGRN/GEP) on Cancer Stem Cell Features

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1806))

Abstract

Emerging evidence suggests that tumors are hierarchically organized with a distinct subpopulation called cancer stem cells (CSCs) lying at the apex of the hierarchy. These cells are not only responsible for tumor initiation and progression but also endowed with stem cell properties, including self-renewal, chemoresistance, and tumor initiation. Although existing therapies can initially eliminate the bulk population of tumor, the stem cell properties of CSCs enable them to survive and repopulate the tumor, resulting in disease relapse. Recently, our group has shown that progranulin (PGRN/GEP) defined a hepatic cancer stem cell subpopulation in hepatocellular carcinoma. This subpopulation demonstrated enhanced ability for colony and spheroid formation, chemoresistance, and tumor initiation. In this chapter, we describe the methods used to isolate the progranulin+ subpopulation and analyze their CSC properties.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. de Lope CR, Tremosini S, Forner A et al (2012) Management of HCC. J Hepatol 56(Suppl 1):S75–S87

    Article  PubMed  CAS  Google Scholar 

  2. Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339–346

    Article  PubMed  CAS  Google Scholar 

  3. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23–28

    Article  PubMed  CAS  Google Scholar 

  4. Reya T, Morrison SJ, Clarke MF et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111

    Article  CAS  PubMed  Google Scholar 

  5. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284

    Article  CAS  PubMed  Google Scholar 

  6. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983–3988

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111–115

    Article  PubMed  CAS  Google Scholar 

  8. Ma S, Chan KW, Hu L et al (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542–2556

    Article  PubMed  CAS  Google Scholar 

  9. Yamashita T, Ji J, Budhu A et al (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136:1012–1024

    Article  PubMed  CAS  Google Scholar 

  10. Cheung PF, Cheng CK, Wong NC et al (2011) Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells. PLoS One 6:e28246

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Yang ZF, Ho DW, Ng MN et al (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13:153–166

    Article  PubMed  CAS  Google Scholar 

  12. Bateman A, Bennett HP (2009) The granulin gene family: from cancer to dementia. BioEssays 31:1245–1254

    Article  PubMed  CAS  Google Scholar 

  13. Cheung ST, Cheung PF, Cheng KC et al (2011) Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 140:344–355

    Article  PubMed  CAS  Google Scholar 

  14. Cheung ST, Wong SY, Lee YT et al (2006) GEP associates with wild-type p53 in hepatocellular carcinoma. Oncol Rep 15:1507–1511

    CAS  PubMed  Google Scholar 

  15. Cheung ST, Wong SY, Leung KL et al (2004) Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 10:7629–7636

    Article  CAS  PubMed  Google Scholar 

  16. Ho JC, Ip YC, Cheung ST et al (2008) Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology 47:1524–1532

    Article  CAS  PubMed  Google Scholar 

  17. Hellsten R, Johansson M, Dahlman A et al (2011) Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells. PLoS One 6:e22118

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707–1710

    Article  PubMed  CAS  Google Scholar 

  19. Celia-Terrassa T, Meca-Cortes O, Mateo F et al (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122:1849–1868

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58

    Article  PubMed  CAS  Google Scholar 

  21. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755–768

    Article  PubMed  CAS  Google Scholar 

  22. Quintana E, Shackleton M, Sabel MS et al (2008) Efficient tumour formation by single human melanoma cells. Nature 456:593–598

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Clarke MF, Fuller M (2006) Stem cells and cancer: two faces of eve. Cell 124:1111–1115

    Article  CAS  PubMed  Google Scholar 

  24. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7:17–23

    PubMed  PubMed Central  CAS  Google Scholar 

  25. Mehta RR, Graves JM, Hart GD et al (1993) Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat 25:65–71

    Article  PubMed  CAS  Google Scholar 

  26. Henson B, Li F, Coatney DD et al (2007) An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. J Oral Pathol Med 36:363–370

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by Hong Kong Research Grants Council (GRF 764111, 764112, and T12-401/13-R), Health and Medical Research Fund (01121566).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Siu Tim Cheung .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Cheung, P.F.Y., Cheung, S.T. (2018). Methods to Analyze the Role of Progranulin (PGRN/GEP) on Cancer Stem Cell Features. In: Bateman, A., Bennett, H., Cheung, S. (eds) Progranulin. Methods in Molecular Biology, vol 1806. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8559-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8559-3_11

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8557-9

  • Online ISBN: 978-1-4939-8559-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics